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Objectives. Women and men enrolled in the Thrombolysis in
Myocardial Infarction (TIMI) IIIB trial of unstable angina and
non–Q wave myocardial infarction (MI) were evaluated to deter-
mine gender differences in characteristics and outcome.
Background. Coronary heart disease is the leading cause of
death for women and men. However, the characteristics and
outcome of women compared with men with unstable angina and
non–Q wave MI have not been extensively studied.
Methods. The characteristics, outcomes and proportion of 497
women and 976 men with unstable angina and non–Q wave MI at
the time of enrollment were compared. When these proportions
were noted to be significantly different, we compared them with
the 7,731-patient TIMI IIIB Registry, which represents the non-
trial, screened population with these syndromes at these centers.
Results. For both coronary syndromes, women were older, were
less frequently white, had a higher incidence of diabetes and
hypertension and were receiving more cardiac medications. The
42-day rate of death and MI in TIMI IIIB was similar for women
and men (7.4% vs. 7.5%). Coronary angiography revealed less
severe coronary artery disease for women than for men, with
absence of critical obstructions in 25% versus 16% and mean
ejection fractions 62 6 12% versus 57 6 13% for women versus
men (p < 0.01). Medical management failed in women as often as
in men, and rates of cardiac catheterization and percutaneous
transluminal coronary angioplasty or coronary artery bypass
graft surgery were similar for women and men in the conservative
strategy arm as well as in the invasive strategy arm. Women in the
TIMI IIIB trial had proportionately more unstable angina than
did men. The proportion of unstable angina and non–Q wave MI
for women was similar in the trial and Registry. However,
proportionately more men in the trial had non–Q wave MI than
men in the Registry.
Conclusions. 1) Women with each acute coronary syndrome are
older than men and have more comorbidity. 2) The outcome with
unstable angina and non–Q wave MI is related to severity of
illness and not gender. 3) Mortality associated with revascular-
ization for unstable angina and non–Q wave MI was similar for
women and men. 4) The proportion of women and men enrolled
with each acute coronary syndrome is different. These rates reflect
both the prevalence of disease and selection bias owing to trial
eligibility criteria and other identified factors.
(J Am Coll Cardiol 1997;30:141–8)
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Coronary heart disease (CHD) is the leading cause of mortal-
ity and morbidity in the United States today in both women
and men. At any given age, the prevalence of CHD is greater
in men than in women. Nonetheless, many recent reports have
concluded that women with CHD have a worse prognosis than
men with this disease (1–4). Gillum (5), using data from the
Centers for Disease Control and Prevention National Center
for Health Statistics, recently reported that the age-adjusted
death rates from ischemic heart disease decreased from 1980
to 1990 much more for men than for women. Several studies
have reported that there is an unequal distribution in the use
of resources between women and men, implying that the
observed differences in outcome may in part relate to resource
utilization. Women have been reported to undergo cardiac
catheterization and consequently revascularization procedures
less often than men (6–8). In addition, the results of revascu-
larization procedures have been reported to be less favorable
in women than in men (9–13).
More than 1.4 million patients are admitted to the hospital
each year in the United States with a diagnosis of an acute
coronary syndrome, either acute Q wave myocardial infarction
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(MI), non–Q wave MI or unstable angina. Although there are
many reports on acute Q wave MI, the characteristics and
outcome of women and men with unstable angina and non–Q
wave MI have not been compared. This data base study
examined the following questions: 1) Are there differences in
the frequency with which women and men present with
unstable angina and non–Q wave MI? 2) Is the higher mortal-
ity observed in women compared with men with Q wave MI
(14) observed for the other acute coronary syndromes? 3) Are
baseline characteristics of women and men with unstable
angina and non–Q wave MI different? And 4) if so, might these
differences explain any observed differences in outcome?
Methods
The Thrombolysis in Myocardial Infarction (TIMI) IIIB
trial enrolled patients diagnosed with unstable, rest angina and
non–Q wave MI. Enrolled were 1,425 men and women ,76
years old with an episode of ischemic pain at rest lasting at
least 5 min but not longer than 6 h and with objective evidence
of ischemic heart disease (15). For a brief period, the trial’s
upper age limit was raised to 79 years for men and women.
Forty-eight patients between 76 and 79 years old were en-
rolled. Patients were excluded if they had undergone previous
coronary artery bypass graft surgery (CABG), had undergone
percutaneous transluminal coronary angioplasty (PTCA)
within 6 months, had experienced an MI within the preceding
21 days, were in cardiogenic shock, had a contraindication to
thrombolytic therapy or heparin, were receiving oral antico-
agulants or had left bundle branch block or a coexistent severe
illness.
All enrolled patients received conventional medical therapy
consisting of oxygen, bed rest and antianginal medications,
including beta-adrenergic blocking agents, calcium antago-
nists, nitrates and heparin to maintain the activated partial
thromboplastin time (APTT) at 1.5 to 2 times the patient’s
baseline value. Aspirin was to be started on day 2 at a dose of
325 mg/day.
Seven hundred twenty-nine patients were randomized to
receive tissue-type plasminogen activator (t-PA) in a front-
loaded, reduced dose regimen of heparin and aspirin, and 744
patients were to receive heparin and aspirin alone. Patients
were also randomized to early invasive or early conservative
strategy, resulting in 740 patients assigned to the early invasive
strategy and 733 patients assigned to the early conservative
strategy. Patients assigned to the early invasive strategy under-
went cardiac catheterization and angiography at 18 to 48 h,
followed by revascularization if anatomically suitable, whereas
patients assigned to the early conservative strategy underwent
cardiac catheterization and angiography only if spontaneous or
provoked ischemia occurred.
To further evaluate our observation that women in the
TIMI IIIB trial had proportionately more unstable angina than
men, we compared the ratios of men and women with unstable
angina and non–Q wave MI in the randomized trial to those
from the nontrial screened population in the TIMI III Registry
(16) at these centers.
Study end points. The primary end point for the t-PA and
placebo comparison was “unsatisfactory outcome,” defined as
the occurrence of either death, nonfatal MI after randomiza-
tion or failure of initial therapy measured at the 6-week visit
(42 to 70 days) after randomization. Failure of initial therapy
included rest angina with electrocardiographic (ECG) changes
as previously described (15), silent ischemia on Holter moni-
toring, an early positive exercise treadmill test or a high risk
thallium scan at hospital discharge and an early positive
exercise treadmill test, unstable angina requiring rehospitaliza-
tion or Canadian Cardiovascular Society class III or IV at the
6-week visit. Adverse events, major hemorrhage and stroke
were also evaluated. The TIMI IIIB trial results have been
previously reported (15).
Statistical considerations. The distribution of baseline
characteristics and clinical course variables were compared by
gender using the chi-square test for categoric data and the
t test for continuous variables. Event rates were estimated
using the Kaplan-Meier method (17), and comparisons among
survival distributions were accomplished using the log-rank
statistic (18).
The Mantel-Haenszel statistic (19) was used to perform
statistical comparisons of binary attribute data by gender while
controlling for study or patient group within the study. The
Breslow-Day statistic (20) was used to test whether gender
odds ratios are consistent among study or patient groups.
Gender analyses for polychotomous data were performed
using polychotomous logistic regression, with terms for gender,
study and gender–study interaction included in the model.
Continuous variables were compared by gender and study
using general linear models (21). Terms for interactions and
main effects were included in each model. Comparisons of time
to event variables between men and women, while adjusting
for patient group, were performed using the Cox proportional
hazards model (22), with terms for main effects (gender and
study group) and interactions included in the model.
Because of the large numbers of statistical comparisons
performed in TIMI IIIB, p , 0.01 was considered to provide
some evidence for an association, and p , 0.001 to provide
strong evidence of an association.
Information from TIMI IIIB was also compared to corre-
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sponding information from the TIMI III Registry. The Regis-
try is composed of two parts: an enumeration roster and a
prospective study. The enumeration roster was used to identify
all patients with unstable angina or non–Q wave MI entering
18 hospitals that also participated in TIMI IIIB and to collect
selected information on these patients. The prospective study
was performed on a subgroup of the enumeration roster
patients. The purpose of this study was to collect more detailed
information on the history and clinical course of unstable
angina and non–Q wave MI in this subgroup. A process of
direct adjustment was used to compare the Registry patients
with the TIMI IIIB group. For each variable collected in the
prospective study, the age-race-gender specific percentage (or
mean) was calculated. These specific percentages or means
were then combined into one summary measure using the
method of direct adjustment. The details of this method have
been presented previously (16).
Results
Patient group. Baseline characteristics in TIMI IIIB. Of the
1,473 patients enrolled in TIMI IIIB, 497 (34%) were women
and 976 (66%) were men; 364 (37%) of 993 patients with
unstable angina and 132 (28%) of 477 patients with non–Q
wave MI were women. The male/female ratio was higher for
those patients with non–Q wave MI (2.6) than for those with
unstable angina (1.7) (p 5 0.001). The male/female ratio for
the 7,731 screened patients ,76 years old in the TIMI III
Registry at 18 hospitals that participated in both TIMI IIIB
and the Registry (17) was similar for patients with non–Q wave
MI (1.36) and unstable angina (1.63). The ratio of unstable
angina to non–Q wave MI for women and men in the
randomized trial, TIMI IIIB, was compared to the TIMI IIIB
Registry. Only patients ,76 years old are included because
TIMI IIIB excluded patients over this age (see Methods
section). The ratio of unstable angina to non–Q wave MI for
women was the same in the trial (3.03) and registry (2.97),
demonstrating that this ratio for women in the trial reflects the
prevalence of each syndrome in hospitalized women. For men,
however, there were significant differences in the ratio (1.96 vs.
3.55, respectively) (p , 0.0001), apparently due to larger
numbers of men with non–Q wave MI in the TIMI IIIB trial.
Overall, women were more often excluded than men from the
trial owing to contraindications to thrombolytic therapy (odds
ratio [OR] 1.17, 95% confidence interval [CI] 1.0 to 1.37, p 5
0.05).
A p value for gender differences is shown to indicate the
differing prevalence of the characteristic in women and men
(Table 1). Women were older, were less frequently white, had
a higher incidence of risk factors and were receiving more
cardiac medications, but they had a lower incidence of previous
MI. At the time of entry into TIMI IIIB, women experienced
the same frequency and duration of ischemic episodes as men.
Although women exhibited ST segment depression or ST
segment elevation on the ECG as often as men did in TIMI
IIIB, T wave inversion was significantly more common in
women with unstable angina than in men with the same
condition. Coronary disease, as evidenced by a previous MI or
a significant stenosis on a previous angiogram, was less often
observed in women in TIMI IIIB. There was a trend toward
less aspirin use in women than in men in the 24 h before the
ischemic event (p 5 0.028).
Outcome of men versus women: non–Q wave MI and
unstable angina. The overall rate of MI and death at 42 days
was similar for women and men in TIMI IIIB. Although
women with non–Q wave MI in TIMI IIIB had a higher event
rate than men (9.8 vs. 7.5), this was not statistically different,
despite the fact that women were significantly older. The
42-day event rate in patients with unstable angina was similar
for the two groups (6.6% for women vs. 7.5% for men). In
TIMI IIIB, an unsatisfactory outcome (death, MI or sponta-
neous or inducible ischemia) at the 6-week visit occurred in
54% of women and 54% of men assigned to receive t-PA. For
women assigned to placebo, the event rate for unsatisfactory
outcome was 53%, similar to the placebo event rate of 57% in
men (p 5 NS). For the end point components making up an
unsatisfactory outcome, spontaneous ischemia was the most
frequent end point and was seen in 29% of women and 27% of
men. Holter monitoring and treadmill exercise testing revealed
abnormalities in a similar percentage of women and men.
However, women were less likely to have a positive high risk
exercise thallium scan (12.7% for women vs. 20.6% for men,
p , 0.001). The outcome profiles for women and men with
each syndrome in TIMI IIIB—unstable angina and non–Q
wave MI—were similar, except for the lower likelihood of a
positive high risk exercise thallium scan for women, as noted.
The profiles and rates of unfavorable outcome were similar for
women and men in each treatment group.
The failure of therapy profile in women with unstable
angina and non–Q wave MI in TIMI IIIB was the same as that
in men in both the early invasive and conservative strategy
arms (Table 2). The components of failure of therapy were also
similar in the two strategies and by gender (Table 2).
Predictors of outcome at 6 weeks for unstable angina and
non–Q wave MI. A multivariate Cox regression model was
used to test the association of 50 baseline variables with the
end point of death or MI through 42 days. Gender did not
relate to outcome for patients with either non–Q wave MI or
unstable angina (p 5 0.767 and p 5 0.463, respectively) or for
the combination (i.e., all TIMI IIIB patients). Increasing age
was associated with death or MI for patients with non–Q wave
MI (p , 0.001), and ST segment depression was prognostically
important for both women and men with unstable angina (OR
2.03, 99% CI 1.09 to 3.80, p 5 0.004). Similarly, the occurrence
of an unsatisfactory outcome (death, nonfatal MI or sponta-
neous or inducible ischemia) was compared for women and
men in each of three age groups: ,55, 55 to 64 and .64 years
old. Of the 493 patients ,55 years old, an unsatisfactory
outcome occurred in 47% (54 of 115) of women compared with
50% (188 of 378) of men; 51% (92 of 179) of women and 55%
(181 of 329) of men 55 to 64 years old; and 59% (120 of 203)
of women and 63% (170 of 269) of men .64 years of age.
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Thus, the overall event rates rose consistently with age, but
within the age groups no significant differences were observed
in the rate of unsatisfactory outcome between women and
men.
Incidence of stroke and hemorrhagic events. In TIMI IIIB,
the incidence of intracranial hemorrhage in patients treated
with a reduced dose of t-PA was 0.40% for women and 0.63%
for men (p 5 NS). The overall rate of any type of stroke at 8
days was similar—0.8% for women and 0.6% for men—as
were the two major spontaneous hemorrhagic event rates
(1.8% vs. 1.3%).
Coronary angiographic findings in TIMI IIIB. Protocol
design specified that all patients randomized to the early
invasive strategy undergo cardiac catheterization. This was
performed in 99% of women and 98% of men. The presence
and extent of coronary artery disease (CAD), defined as $60%
stenosis in one or more major arteries, was significantly
different in women than in men. More women than men did
not have a critical obstruction (25% vs. 16%), and women had
multivessel CAD less often than men (37% vs. 47%) (p ,
0.005 for CAD gender differences) (Table 3). The percent
stenosis in the culprit artery and TIMI flow grade were similar
for women and men. Preserved left ventricular systolic func-
tion, as measured by an ejection fraction .55% was more
common in women than in men (74% vs. 56%, p , 0.01). The
mean ejection fraction for women was 62 6 12%, for men 57 6
13% (p , 0.01). Patients assigned to the early conservative
strategy were to undergo cardiac catheterization after the
occurrence of an unsatisfactory outcome. Because of the
similarity in the occurrence of unsatisfactory outcome in men
and women, it is not surprising that a similar percentage (61%
of women vs. 65% of men) assigned to the conservative
strategy underwent cardiac catheterization (p 5 NS).
Revascularization procedures in men and women. There
was a smaller percentage of women receiving CABG in TIMI
IIIB (19% vs. 27%, p , 0.001), presumably because of the
lower incidence of multivessel disease. Similar differences were
observed in both the invasive strategy and conservative strat-
egy. Overall, PTCA was performed equally in women and men
(33% and 32%, respectively) both in the invasive and conser-
vative strategies.
The most important independent predictors of the perfor-
mance of revascularization in the invasive arm were race (with
blacks undergoing revascularization less frequently), the pres-
Table 1. TIMI IIIB Patients: Comparison of Baseline Characteristics by Gender
Men (N 5 976) Women (N 5 497)
N n % (mean) N n % (mean) p Value*
Age (yr)
,55 976 378 38.7 497 115 23.1 —
55–64 976 329 33.7 497 179 36.0 —
$65 976 269 27.6 497 203 40.8 0.000
Mean 976 — (57.6) 497 — (61.2) 0.000
Race (white) 976 808 82.8 497 366 73.6 0.000
Past medical history
History of smoking 976 73.1 74.9 497 284 57.1 0.000
Diabetes mellitus 527 62 11.8 255 52 20.4 0.001
Hypertension 965 338 35.0 492 277 56.3 0.000
Family history of CAD 929 365 39.3 483 207 42.9 0.195
History of angina 976 831 85.1 497 429 86.3 0.545
History of MI 976 444 45.5 497 153 30.8 0.000
Medications in previous week
Nitrates 976 442 45.3 497 257 51.7 0.020
Beta-blockers 976 309 31.7 497 192 38.6 0.008
Calcium channel blockers 976 405 41.5 497 223 44.9 0.216
Aspirin ,24 h before event 976 487 49.9 497 218 43.9 0.028
Heparin 976 137 14.0 497 85 17.1 0.120
Diuretic agents 976 114 11.7 497 128 25.8 0.000
ACE inhibitors 976 79 8.1 497 69 13.9 0.000
Presenting illness
Number of episodes of pain in last 24 h 976 — (3.1) 497 — (3.1) 0.966
Length of qualifying episode of pain (h) 906 — (1.9) 467 — (2.0) 0.773
Time from pain to treatment (h) 967 — (9.1) 483 — (9.1) 0.918
Admission criteria
ST segment elevation 975 102 10.5 497 49 9.9 0.719
ST segment depression 974 305 31.3 497 175 35.2 0.132
T wave changes 974 419 43.0 497 264 53.1 0.000
Previous angiogram with stenosis 974 349 35.8 497 134 27.0 0.001
*Value derived from chi-square or F test statistic comparing distributions among the two groups. ACE 5 angiotensin-converting enzyme; CAD 5 coronary artery
disease; MI 5 myocardial infarction; N 5 total number of patients evaluated; n 5 number of patients with attribute.
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ence of ST segment depression and ST segment elevation and
the number of diseased vessels (all p , 0.01). Independent
predictors of revascularization in the conservative strategy
included race, with blacks undergoing PTCA or CABG less
frequently; history of angina; use of heparin at time of study
entry; and presence of ST segment depression on the qualify-
ing ECG (all p , 0.002). Gender, when forced into both of
these analyses, did not relate to performance of revasculariza-
tion when all other variables were taken into account.
For all patients undergoing PTCA by hospital discharge
(invasive and conservative strategies, 150 women and 294
men), the occurrence of a complication—death, MI, stroke or
CABG at 42 days after performance of PTCA—was similar for
women and men (9.3% vs. 8.5%, p 5 0.77) (23). For all
patients in the conservative and invasive strategies, the mor-
tality rate at 42 days for women undergoing CABG was 8.5%
compared with 2.2% for men (p 5 0.05). Because there were
only seven deaths after CABG, results of multivariate analysis
to assess the effect of age, body surface area and other
variables are unreliable.
Discussion
Coronary heart disease is the leading cause of death of
women in the United States, accounting for more than one-
third of all deaths. Only recently has intense interest been
focused on the diagnosis of and factors related to the outcome
of women with this disease. Most clinical trials have enrolled
primarily men, and the results have generally been extrapo-
lated to women. Furthermore, observations made in the recent
past suggest that such extrapolation of specific results found in
men may not be appropriate (8,24,25).
Among the 1.4 million hospital admissions for acute coro-
nary syndromes each year in the United States, unstable angina
and non–Q wave MI are responsible for more than 750,000
admissions. The TIMI IIIB trial is the largest randomized trial
Table 2. Failure of Therapy Profile at 6 Weeks for Men and Women by Strategy and Non–Q Wave Myocardial Infarction Status: TIMI IIIB
Non–Q Wave MI Unstable Angina All Patients
Men Women Men Women Men Women
No. % No. % No. % No. % No. % No. %
Invasive strategy
Death 6 3.4 3 4.0 7 2.3 2 1.2 13 2.6 5 2.0
MI 8 4.5 2 2.7 19 6.1 9 5.2 27 5.5 11 4.4
Positive 6-week ETT 9 5.0 6 8.0 29 9.3 16 9.2 39 7.9 22 8.8
No end point 156 87.2 64 85.3 256 82.3 146 84.4 412 83.9 211 84.7
p value* 0.7 0.2 0.8
Conservative strategy
Death 5 3.0 6 10.5 2 0.6 5 2.6 7 1.4 11 4.4
MI 8 4.8 2 3.5 21 6.6 11 5.8 29 6.0 13 5.2
Positive 6-week ETT 15 9.0 5 8.8 29 9.1 19 9.9 44 9.1 24 9.7
No end point 138 83.1 44 77.2 266 83.6 156 81.7 405 83.5 200 80.6
p value* 0.817 0.294 0.095
*Value obtained from a chi-square statistic comparing the distribution between the groups. ETT 5 exercise treadmill test; MI 5 myocardial infarction.
Table 3. TIMI IIIB Patients Who Had Invasive Strategy: Comparison of Angiographic Findings by Gender
Men (N 5 491) Women (N 5 249)
p Value*N n % (mean) N n % (mean)
Angiographic data
No. vessels with stenosis $60%
0 475 75 15.8 245 60 24.5
1 475 178 37.5 245 94 38.4
2 475 141 29.7 245 67 27.3
3 475 81 17.1 245 24 9.8 0.005
Ejection fraction
,35% 457 23 5.0 242 3 1.2
35–55% 457 178 38.9 242 60 24.8
.55% 457 256 56.0 242 179 74.0 0.000
Mean 457 — (56.8) 242 — (62.0) 0.000
Stenosis in culprit artery 324 — (84.7) 157 — (83.2) 0.253
Culprit lesion flow grade 308 — (2.2) 148 — (2.4) 0.047
*Values derived from a chi-square or F test statistic comparing distributions among the two groups. Abbreviations as in Table 1.
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performed to date, enrolling both men and women with
unstable angina and non–Q wave MI. The design of the trial
focused on the management of patients with these syndromes
and called for the same strategy to be used in men and women.
Therefore, the outcomes observed in this trial for men and
women are less likely to be related to possible treatment bias.
In addition, the number of women enrolled in TIMI IIIB was
large enough to allow for statistical comparison, which was not
the case for most other investigations. Extensive clinical and
angiographic data were collected.
At presentation, women were older and had more hyper-
tension and diabetes. During the week before study enroll-
ment, women were more often treated with nitrates, beta-
blockers and calcium channel blockers than were men, and
there was a trend (p , 0.02) for them to be treated less often
with aspirin during this period. Lower rates of aspirin use in
women were noted in the Survival and Ventricular Enlarge-
ment (7) and Determinants of Myocardial Infarction Onset
Study (Muller J, personal communication, 1996). This may be
the result of the mistaken concept that women do not derive
benefit from aspirin. The meta-analysis on aspirin use for CHD
(26) demonstrated clear benefit for women as well as men.
Outcomes for men and women in TIMI IIIB. The occur-
rence of major events—death or MI—was similar for men and
women in TIMI IIIB. This was seen even though women less
often had a previous MI, better left ventricular function and
less extensive coronary disease, each of which should have
correlated with a better outcome. The older age and greater
prevalence of diabetes and hypertension among women may
have counterbalanced the other more favorable characteristics.
However, other pathophysiologic differences between men and
women may help explain the similar outcome, despite less
coronary disease and better ventricular function in women. In
fact, the presence of other gender differences is suggested by
the greater risk-adjusted rate of death for women with ST
segment elevation and Q wave MI in other studies (2,16,27,28).
These findings may result from gender differences in the
balance of prothrombotic and antithrombotic forces (29–37).
Less collateral blood flow has been reported for women (38),
which could explain the finding in TIMI IIIB and other studies
of more anginal symptoms and more antianginal medication
use in women despite their less severe CAD. It would also
explain the increased occurrence of certain complications of
acute MI in women that may relate to more extensive trans-
murality of the infarction, such as cardiogenic shock and
cardiac rupture (39–43).
For both women and men, the most important clinical
variables predictive of outcome in TIMI IIIB were age and the
presence of ST segment depression. Our results are similar to
the Veterans Administration study on unstable angina (44) of
men only, which identified similar variables as predictive of
outcome. These clinical factors should prove useful in devel-
oping reasonable management strategies for physicians caring
for patients of either gender with unstable angina and non–Q
wave MI. Women with ST segment deviation have a greater
likelihood of sustaining a MI or reinfarction or dying than
those with no ECG changes or with T wave inversion. Further-
more, the success rate of PTCA was high, and there was a low
complication rate in women. Therefore, a reasonable strategy
for women as well as men is early cardiac catheterization and
revascularization for those who have ST segment deviation on
the ECG at presentation.
In TIMI IIIB, which used a reduced dose of t-PA, there was
no difference in the rate of intracranial hemorrhage between
men and women. This is in contrast to TIMI II (14), the
International Tissue Plasminogen Activator/Streptokinase
Mortality trial (45) and Gruppo Italiano per lo Studio della
Streptochinasi nell’Infarto Miocardico (GUSTO) (27), which
all reported increased bleeding complications in women
treated with full-dose thrombolytic agents (46). Further inves-
tigation of weight- or size-adjusted doses of thrombolytic
agents and adjunctive anticoagulant agents is needed.
Angiography and revascularization. It is interesting that
one of four women who met strict criteria for rest angina and
ECG changes or previous documented disease had no signifi-
cant obstructive coronary disease. This is consistent with the
finding that syndrome X and variant angina are more common
in women than in men (47). The relative importance of fixed
coronary stenoses, abnormalities in vasodilator reserve and
abnormalities in coronary tone with or without vasospasm as
the etiology of exertional and rest ischemia in women is the
subject of current investigation.
The utilization of resources by women compared with men
has been the focus of many recent reports (6–8,48–51). The
TIMI IIIB protocol mandated coronary angiography in 50% of
the patients assigned to that strategy. It revealed less extensive
coronary disease in women, which is consistent with the
findings of the Coronary Artery Surgery Study (CASS) of
patients with chronic stable angina (52). Preserved left ventric-
ular function was also seen more often in women in TIMI IIIB
and is also consistent with a report from the Survival and
Ventricular Enlargement (7) and CASS (52) trials.
In the early conservative strategy, coronary angiography
and revascularization were required only if the therapy failed
the patient. Women and men assigned to this strategy under-
went cardiac catheterization at the same rates, reflecting that
initial management failed women and men at similar rates and
that there was no gender referral bias. The severity of the
presenting illness and coronary anatomy, rather than gender,
were the predictors of revascularization. Revascularization
procedures were performed at similar rates for men and
women in both the invasive and early conservative strategy
arms. Coronary artery bypass graft surgery was less often
performed in women, because they had less multivessel CAD
and more often preserved left ventricular function compared
with men.
Relation of men to women across the acute coronary
syndromes. The comparison of unstable angina and non–Q
wave MI between men and women could potentially offer
insight into gender differences in the mode of presentation of
patients hospitalized with CHD. There was a greater propor-
tion of women with unstable angina (37%) than with non–Q
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wave MI (28%) in the TIMI IIIB randomized trial. The
similarly designed TIMI II trial for patients treated with
thrombolytic agents for MI with ST segment elevation re-
ported an even lower proportion of women (18%) (14). The
GUSTO trial, which had no upper age limit, and an overview
of large thrombolytic trials showed similar low percentages
(24%) of women (27,53). Women are excluded from throm-
bolytic administration more often than men, and this is both
due to older age and other factors independent of age (54–57).
This was also reported in a population study from Minnesota,
where women ,75 years old received thrombolytic agents less
often than did men (35% vs. 45%) (p , 0.05), including those
with ST segment elevations and no obvious contraindication to
thrombolysis (74% vs. 85%, p 5 0.09) (56). A review of the
TIMI III Registry confirmed that women were more often
excluded from the randomized trial (TIMI IIIB) than men
owing to contraindications to thrombolytic therapy. Recent
comparisons in other thrombolytic trials with no upper age
limit demonstrated that women comprised only 22% of the
trial cohort, compared with 37% of the nontrial cohort (56).
Nevertheless, a recent report from a study of the Glasgow
population confirmed that women with cardiac events more
often have nonspecific ST-T segment changes and probable
MI, and men more often have definite Q wave MI (57). These
and our data strongly suggest that the proportion of women
enrolled with different acute coronary syndromes (i.e., MI with
ST segment elevation, non–Q wave MI and unstable angina)
reflects both the differential rates of each syndrome in men and
women and selection factors affecting enrollment in clinical
trials that require thrombolytic eligibility. The TIMI III Reg-
istry more accurately represents the true proportion of male
and female patients with unstable angina and non–Q wave MI
hospitalized for these syndromes. Lower overall proportions of
women enrolled in TIMI IIIB compared with the TIMI III
Registry (16) are explained by these selection factors, an upper
age limit and ineligibility to receive a thrombolytic agent.
However, the greater proportion of women with unstable
angina compared with non–Q wave MI in the trial, compared
with those age ,76 years old in the Registry, is not readily
explained. The similar ratio of unstable angina to non–Q wave
MI for women in the trial compared with the Registry, but the
lower ratio of unstable angina to non–Q wave MI for men in
the trial compared with the Registry, may indicate that a
disproportionate number of men with non–Q wave MI were
enrolled, not that women with non–Q wave MI were excluded.
Conclusions. The TIMI IIIB trial is the largest study to
date to examine the differences and similarities between
women and men with unstable angina and non–Q wave MI.
We conclude that 1) the proportion of women and men
enrolled with each of the two acute coronary syndromes—
unstable angina and non–Q wave MI—differed, which appears
to reflect disproportionate enrollment of men with non–Q
wave MI; 2) women with each acute coronary syndrome are
significantly older than men and have more comorbidity; 3) the
outcome of women with unstable angina and non–Q wave MI
is similar to that of men and is related to the severity of illness
rather than to gender itself; and 4) women undergoing revas-
cularization for unstable angina and non–Q wave MI have a
mortality rate similar to that of men.
We thank Iris Barreras for expert secretarial assistance and Emilie Godfrey, MS,
RD for assistance in editing the manuscript.
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